TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 305 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40,119,119 | +3.1% | 2,593,350 | +4.7% | 0.00% | 0.0% |
| Q2 2023 | $38,919,994 | -52.6% | 2,477,403 | -50.3% | 0.00% | -25.0% |
| Q1 2023 | $82,169,954 | +128.6% | 4,986,042 | +116.4% | 0.00% | 0.0% |
| Q4 2022 | $35,940,525 | +37.9% | 2,303,880 | +14.6% | 0.00% | +33.3% |
| Q3 2022 | $26,069,000 | +0.1% | 2,009,910 | +8.4% | 0.00% | 0.0% |
| Q2 2022 | $26,030,000 | -25.8% | 1,853,992 | -24.3% | 0.00% | 0.0% |
| Q1 2022 | $35,058,000 | +33.8% | 2,448,204 | +27.4% | 0.00% | +50.0% |
| Q4 2021 | $26,199,000 | -10.0% | 1,922,205 | +8.2% | 0.00% | 0.0% |
| Q3 2021 | $29,113,000 | +11.0% | 1,777,325 | +14.1% | 0.00% | 0.0% |
| Q2 2021 | $26,223,000 | +11.6% | 1,558,140 | +21.1% | 0.00% | 0.0% |
| Q1 2021 | $23,489,000 | +35.0% | 1,286,376 | +34.6% | 0.00% | 0.0% |
| Q4 2020 | $17,399,000 | +3.1% | 956,023 | +1.1% | 0.00% | 0.0% |
| Q3 2020 | $16,875,000 | -4.8% | 945,894 | -4.3% | 0.00% | 0.0% |
| Q2 2020 | $17,723,000 | +32.1% | 988,486 | +11.8% | 0.00% | 0.0% |
| Q1 2020 | $13,416,000 | +22.4% | 883,794 | +59.1% | 0.00% | +100.0% |
| Q4 2019 | $10,962,000 | +5.3% | 555,610 | -8.2% | 0.00% | 0.0% |
| Q3 2019 | $10,406,000 | -78.3% | 604,994 | -77.7% | 0.00% | -83.3% |
| Q2 2019 | $47,937,000 | -68.9% | 2,708,306 | -64.2% | 0.01% | -66.7% |
| Q1 2019 | $154,063,000 | +15406200.0% | 7,563,259 | +9453973.8% | 0.02% | – |
| Q4 2018 | $1,000 | – | 80 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |